Evidence map›Paper›PMID 15969767›Full record

ArticleBMC immunology2005

Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.

David H Dreyfus, Masayuki Nagasawa, Erwin W Gelfand, Lucy Y Ghoda

Abstract readComparative Study
In one paragraph

Article in BMC immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.International journal of molecular sciences · 2016
    Review
  9. Review
  10. Article
  11. Reovirus receptors, cell entry, and proapoptotic signaling.Advances in experimental medicine and biology · 2013
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David H DreyfusDivision of Basic Sciences, Department of Pediatrics, National Jewish Medical Research Center, Denver, CO 80262 USA. dhdreyfus@pol.net
Masayuki Nagasawa
Erwin W Gelfand
Lucy Y Ghoda

Funding

Signaling Memory in Chronic AsthmaP01HL036577 · NHLBI · NATIONAL JEWISH HEALTH · PI GELFAND, ERWIN WILLIAM · 1986 to 2011
$18.7M
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESSR01HL061005 · NHLBI · NATIONAL JEWISH HEALTH · PI GELFAND, ERWIN WILLIAM · 1999 to 2007
$2.2M
REGULATION OF MAST CELL CYTOKINE PRODUCTIONR01AI042246 · NIAID · NATIONAL JEWISH HEALTH · PI GELFAND, ERWIN WILLIAM · 1998 to 2002
$826k
MEKK2 Regulation of Mast Cell/T Cell Cytokine ProductionR21AI042246 · NIAID · NATIONAL JEWISH HEALTH · PI GELFAND, ERWIN WILLIAM · 2003 to 2003
$283k
INTRACELLULAR STABILITY OF ORNITHINE DECARBOXYLASER21GM049055 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI GHODA, LUCY Y · 1994 to 1995
–
NHLBI NIH HHS HL36577NHLBI NIH HHS HL61005NHLBI NIH HHS P01 HL036577NHLBI NIH HHS R01 HL061005NIAID NIH HHS AI42246NIGMS NIH HHS GM049055
6 · The paper itself

Abstract

backgroundIn this work we present evidence that the p53 tumor suppressor protein and NF-kappaB transcription factors could be related through common descent from a family of ancestral transcription factors regulating cellular proliferation and apoptosis. P53 is a homotetrameric transcription factor known to interact with the ankyrin protein 53BP2 (a fragment of the ASPP2 protein). NF-kappaB is also regulated by ankyrin proteins, the prototype of which is the IkappaB family. The DNA binding sequences of the two transcription factors are similar, sharing 8 out of 10 nucleotides. Interactions between the two proteins, both direct and indirect, have been noted previously and the two proteins play central roles in the control of proliferation and apoptosis.

resultsUsing previously published structure data, we noted a significant degree of structural alignment between p53 and NF-kappaB p65. We also determined that IkappaBalpha and p53 bind in vitro through a specific interaction in part involving the DNA binding region of p53, or a region proximal to it, and the amino terminus of IkappaBalpha independently or cooperatively with the ankyrin 3 domain of IkappaBalpha In cotransfection experiments, kappaBalpha could significantly inhibit the transcriptional activity of p53. Inhibition of p53-mediated transcription was increased by deletion of the ankyrin 2, 4, or 5 domains of IkappaBalpha Co-precipitation experiments using the stably transfected ankyrin 5 deletion mutant of kappaBalpha and endogenous wild-type p53 further support the hypothesis that p53 and IkappaBalpha can physically interact in vivo.

conclusionThe aggregate results obtained using bacterially produced IkappaBalpha and p53 as well as reticulocyte lysate produced proteins suggest a correlation between in vitro co-precipitation in at least one of the systems and in vivo p53 inhibitory activity. These observations argue for a mechanism involving direct binding of IkappaBalpha to p53 in the inhibition of p53 transcriptional activity, analogous to the inhibition of NF-kappaB by kappaBalpha and p53 by 53BP2/ASPP2. These data furthermore suggest a role for ankyrin proteins in the regulation of p53 activity. Taken together, the NFkappaB and p53 proteins share similarities in structure, DNA binding sites and binding and regulation by ankyrin proteins in support of our hypothesis that the two proteins share common descent from an ancestral transcriptional factor.

Indexed as

Evolution, MolecularAmino Acid SequenceAnimalsAnkyrin RepeatBinding SitesBurkitt LymphomaCell Line, TumorChlorocebus aethiopsConsensus SequenceCOS CellsHumansI-kappa B ProteinsModels, MolecularMolecular Sequence DataMultigene FamilyMutagenesisI-kappa B ProteinsNF-KappaB Inhibitor alphaNFKBIA protein, humanRecombinant Fusion ProteinsTranscription Factor RelATumor Suppressor Protein p53

Identifiers

PMID15969767
PMCPMC1184076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.